| The 2021 WHO classification of tumors of the central nervous system: a summary DN Louis, A Perry, P Wesseling, DJ Brat, IA Cree, D Figarella-Branger, ... Neuro-oncology 23 (8), 1231-1251, 2021 | 7853 | 2021 |
| The 2019 WHO classification of tumours of the digestive system ID Nagtegaal, RD Odze, D Klimstra, V Paradis, M Rugge, P Schirmacher, ... Histopathology 76 (2), 182, 2019 | 3066 | 2019 |
| Locality sensitive deep learning for detection and classification of nuclei in routine colon cancer histology images K Sirinukunwattana, SEA Raza, YW Tsang, DRJ Snead, IA Cree, ... IEEE transactions on medical imaging 35 (5), 1196-1206, 2016 | 1363 | 2016 |
| A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal G Rindi, DS Klimstra, B Abedi-Ardekani, SL Asa, FT Bosman, E Brambilla, ... Modern Pathology 31 (12), 1770-1786, 2018 | 1055 | 2018 |
| The 2019 WHO classification of tumours of the breast PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ... Histopathology 77 (2), 2020 | 665 | 2020 |
| cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading DN Louis, P Wesseling, K Aldape, DJ Brat, D Capper, IA Cree, C Eberhart, ... Brain Pathology 30 (4), 844-856, 2020 | 543 | 2020 |
| The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway DE Elder, BC Bastian, IA Cree, D Massi, RA Scolyer Archives of pathology & laboratory medicine 144 (4), 500-522, 2020 | 457 | 2020 |
| The 2022 World Health Organization classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours H Moch, MB Amin, DM Berney, EM Compérat, AJ Gill, A Hartmann, ... European urology 82 (5), 458-468, 2022 | 448 | 2022 |
| Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma PE Andreotti, IA Cree, CM Kurbacher, DM Hartmann, D Linder, G Harel, ... Cancer research 55 (22), 5276-5282, 1995 | 417 | 1995 |
| Comparison of MTT and ATP‐based assays for the measurement of viable cell number RD Petty, LA Sutherland, EM Hunter, IA Cree Journal of bioluminescence and chemiluminescence 10 (1), 29-34, 1995 | 376 | 1995 |
| Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol L Ramage, BJ Lipworth, CG Ingram, IA Cree, DP Dhillon Respiratory medicine 88 (5), 363-368, 1994 | 330 | 1994 |
| Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion SR Boyd, I Zachary, U Chakravarthy, GJ Allen, GB Wisdom, IA Cree, ... Archives of ophthalmology 120 (12), 1644-1650, 2002 | 324 | 2002 |
| Molecular chess? Hallmarks of anti-cancer drug resistance IA Cree, P Charlton BMC cancer 17, 1-8, 2017 | 306 | 2017 |
| C-reactive protein: a clinical marker in community-acquired pneumonia RP Smith, BJ Lipworth, IA Cree, EM Spiers, JH Winter Chest 108 (5), 1288-1291, 1995 | 275 | 1995 |
| Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival C Jenkins, GE Rose, C Bunce, JE Wright, IA Cree, N Plowman, ... British journal of ophthalmology 84 (8), 907-913, 2000 | 266 | 2000 |
| Validation of digital pathology imaging for primary histopathological diagnosis DRJ Snead, YW Tsang, A Meskiri, PK Kimani, R Crossman, NM Rajpoot, ... Histopathology 68 (7), 1063-1072, 2016 | 262 | 2016 |
| Guidance for laboratories performing molecular pathology for cancer patients IA Cree, Z Deans, MJL Ligtenberg, N Normanno, A Edsjö, E Rouleau, ... Journal of clinical pathology 67 (11), 923-931, 2014 | 229 | 2014 |
| Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells G Geerling, JT Daniels, JKG Dart, IA Cree, PT Khaw Investigative ophthalmology & visual science 42 (5), 948-956, 2001 | 206 | 2001 |
| Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer CM Kurbacher, IA Cree, HW Bruckner, U Brenne, JA Kurbacher, K Müller, ... Anti-cancer drugs 9 (1), 51-57, 1998 | 205 | 1998 |
| The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical … PI Gonzalez‐Ericsson, ES Stovgaard, LF Sua, E Reisenbichler, Z Kos, ... The Journal of pathology 250 (5), 667-684, 2020 | 187 | 2020 |
